Guru Banavar

Dr. Guru Banavar


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2021 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
GBGuru Banavar
Guru Banavar
OOOyetunji Ogundijo
Oyetunji Ogundijo
RTRyan Toma
Ryan Toma
SRSathyapriya Rajagopal
Sathyapriya Rajagopal
YLYen Kai Lim
Yen Kai Lim
Chamindie K. PunyadeeraChamindie K. Punyadeera
Chamindie K. Punyadeera
Despite advances in cancer treatment, the 5-year mortality rate for oral cancers (OC) is 40%, mainly due to the lack of early diagnostics. To advance early diagnostics for high-risk and average-risk populations, we developed and evaluated machine-learning (ML) classifiers using metatranscriptomic data from saliva samples (n = 433) collected from oral premalignant disorders (OPMD), OC patients (n = 71) and normal controls (n = 171). Our diagnostic classifiers yielded a receiver operating characteristics (ROC) area under the curve (AUC) up to 0.9, sensitivity up to 83% (92.3% for stage 1 cancer) and specificity up to 97.9%. Our metatranscriptomic signature incorporates both taxonomic and functional microbiome features, and reveals a number of taxa and functional pathways associated with OC. We demonstrate the potential clinical utility of an AI/ML model for diagnosing OC early, opening a new era of non-invasive diagnostics, enabling early intervention and improved patient outcomes.

19 November 2021 in Diabetes Therapy
Verified
Journal Article
Open access
PDF file
HTHal Tily
Hal Tily
Eric PatridgeEric Patridge
Eric Patridge
YCYing Cai
Ying Cai
VGVishakh Gopu
Vishakh Gopu
SGStephanie Gline
Stephanie Gline
GBGuru Banavar
Guru Banavar
Limiting postprandial glycemic response (PPGR) is an important intervention in reducing the risk of chronic metabolic diseases and has been shown to impart significant health benefits in people with elevated levels of blood sugar. In this study, we collected gut microbiome activity data by assessing the metatranscriptome, and we measured the glycemic responses of 550 adults who consumed more than 30,000 meals, collectively, from omnivore or vegetarian/gluten-free diets. We demonstrate that gut microbiome activity, anthropometric factors, and food macronutrients modulate individual variation in glycemic response. We employ two predictive models, including a mixed-effects linear regression model (R = 0.77) and a gradient boosting machine model (Rtrain = 0.80/R2train = 0.64; Rtest = 0.64/R2test = 0.40), which demonstrate variation in PPGR between individuals when ingesting the same foods. All features in the final mixed-effects linear regression model were significant (p < 0.05) except for two features which were retained as suggestive: glutamine production pathways (p = 0.08) and the interaction between tyrosine metabolizers and carbs (p = 0.06). We introduce molecular functions as features in these two models, aggregated from microbial activity data, and show their statistically significant contributions to glycemic control. In summary, we demonstrate for the first time that metatranscriptomic activity of the gut microbiome is correlated with PPGR among adults.

14 July 2023 in Oral Oncology
Verified
Journal Article
Closed access
GBGuru Banavar
Guru Banavar
OOOyetunji Ogundijo
Oyetunji Ogundijo
CJCristina Julian
Cristina Julian
RTRyan Toma
Ryan Toma
FCFrancine Camacho
Francine Camacho
Chamindie K. PunyadeeraChamindie K. Punyadeera
Chamindie K. Punyadeera

2 December 2023 in iScience
Verified
Journal Article
Open access
VGVishakh Gopu
Vishakh Gopu
FCFrancine R. Camacho
Francine R. Camacho
RTRyan Toma
Ryan Toma
PTPedro J. Torres
Pedro J. Torres
YCYing Cai
Ying Cai
GBGuru Banavar
Guru Banavar
Accurate measurement of the biological markers of the aging process could provide an “aging clock” measuring predicted longevity and enable the quantification of the effects of specific lifestyle choices on healthy aging. Using machine learning techniques, we demonstrate that chronological age can be predicted accurately from (1) the expression level of human genes in capillary blood and (2) the expression level of microbial genes in stool samples. The latter uses a very large metatranscriptomic dataset, stool samples from 90,303 individuals, which arguably results in a higher quality microbiome-aging model than prior work. Our analysis suggests associations between biological age and lifestyle/health factors, e.g., people on a paleo diet or with IBS tend to have higher model-predicted ages and people on a vegetarian diet tend to have lower model-predicted ages. We delineate the key pathways of systems-level biological decline based on the age-specific features of our model.

1 October 2019 in International Journal of Genomics
Verified
Journal Article
Open access
PDF file
AHAndrew Hatch
Andrew Hatch
JHJames Horne
James Horne
RTRyan Toma
Ryan Toma
BTBrittany L. Twibell
Brittany L. Twibell
KSKalie M. Somerville
Kalie M. Somerville
MVMomchilo Vuyisich
Momchilo Vuyisich
A functional readout of the gut microbiome is necessary to enable precise control of the gut microbiome’s functions, which support human health and prevent or minimize a wide range of chronic diseases. Stool metatranscriptomic analysis offers a comprehensive functional view of the gut microbiome, but despite its usefulness, it has rarely been used in clinical studies due to its complexity, cost, and bioinformatic challenges. This method has also received criticism due to potential intrasample variability, rapid changes, and RNA degradation. Here, we describe a robust and automated stool metatranscriptomic method, called Viomega, which was specifically developed for population-scale studies. Viomega includes sample collection, ambient temperature sample preservation, total RNA extraction, physical removal of ribosomal RNAs (rRNAs), preparation of directional Illumina libraries, Illumina sequencing, taxonomic classification based on a database of >110,000 microbial genomes, and quantitative microbial gene expression analysis using a database of ~100 million microbial genes. We applied this method to 10,000 human stool samples and performed several small-scale studies to demonstrate sample stability and consistency. In summary, Viomega is an inexpensive, high-throughput, automated, and accurate sample-to-result stool metatranscriptomic technology platform for large-scale studies and a wide range of applications.

10 August 2020 in BioTechniques
Verified
Journal Article
Open access
RTRyan Toma
Ryan Toma
NDNathan Duval
Nathan Duval
BPBenjamin Pelle
Benjamin Pelle
MPMatthew M Parks
Matthew M Parks
VGVishakh Gopu
Vishakh Gopu
MVMomchilo Vuyisich
Momchilo Vuyisich
To prevent and treat chronic diseases, including cancer, a global application of systems biology is needed. We report here a whole blood transcriptome test that needs only 50 μl of capillary (finge... METHOD SUMMARY This report describes an important improvement to whole blood transcriptome analysis. While current methods are complicated and expensive, the method reported here includes at-home s...